GSK3B and B-cell chronic lymphocytic leukemia: Strikingly, PLA signals were reduced in CLL cells treated with SB216763 and MG132 compared with cells treated with MG132 alone (Fig. 3D), indicating that lower amounts of N1-ICD undergo ubiquitin-proteasome pathway when GSK3β is less active.